Slide 1 - Patterns of Care in Medical Oncology
Slide 2 - Clinical Use of Adjuvant Trastuzumab
Slide 3 - Clinical Use of Adjuvant Trastuzumab
Slide 4 - Approach to Adjuvant Therapy for ER-Negative, HER2-Positive Disease: Negative Nodes
Slide 5 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative
Slide 6 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative (continued)
Slide 7 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative (continued)
Slide 8 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative (continued)
Slide 9 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative (continued)
Slide 10 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: High Risk, Node-Negative (continued)
Slide 11 - Approach to Therapy for ER/PR-Positive, HER2-Positive Disease
Slide 12- Approach to Therapy for ER/PR-Positive, HER2-Positive Disease (continued)
Slide 13 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes
Slide 14 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes (continued)
Slide 15 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes (continued)
Slide 16 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes (continued)
Slide 17 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes (continued)
Slide 18 - Adjuvant Therapy for ER/PR-Negative, HER2-Positive Disease: Positive Nodes (continued)
Slide 19 - Use of Delayed Adjuvant Trastuzumab
Slide 20 - Use of Delayed Adjuvant Trastuzumab (continued)
Slide 21 - Impact of Cardiac Status on Use of Adjuvant Trastuzumab
Slide 22 - Impact of Cardiac Status on Use of Adjuvant Trastuzumab (continued)
Slide 23 - Impact of Cardiac Status on Use of Adjuvant Trastuzumab
Slide 24 - Impact of Cardiac Status on Use of Adjuvant Trastuzumab (continued)
Slide 25 - HER2 Testing and Use of Adjuvant Trastuzumab
Slide 26 - Cardiac Function Testing and Use of Adjuvant Trastuzumab
Slide 27 - Use of Trastuzumab in the Metastatic Setting after Adjuvant Treatment
